Synthesis and Crystallographic, Absorption and Emission Studies of 4-Pyridine Carboxamide of Zn(II) 4-Chlorophenylacetate

A new zinc(II) complex, [Zn(CB)₂(INA)₂] (where CB is 4-chlorophenylacetate and INA is 4-pyridine carboxamide) was synthesized. The structure of the complex was characterized by elemental analysis, FT-IR spectroscopy and single-crystal X-ray diffraction technique. Besides, the thermal stability of the complex was investigated by TGA/DTA analysis method. Moreover, the optical absorption and the emission features of the complex were examined by using UV-Vis and fluorescence spectrophotometers, respectively. Furthermore, Density Functional Theory (DFT) calculations were carried out to support the experimental results. Accordingly, it was determined that the complex crystallized in a monoclinic system with space group Pc, a = 8.3329 (2) Å, b = 25.6530 (4) Å, c = 13.5048 (3) Å, α = 90°, β = 91.703 (3)° and γ = 90°. The complex consists two crystallographically independent molecules. In each molecule, the Zn^II ion adopts a distorted trigonal pyramidal coordination formed by two O atoms from the two 4 chlorophenylacetate ligand and two N atoms of the two 4-pyridine carboxamide ligands. It was observed that the linear absorption spectra of the complex were similar to linear absorption spectra of the semiconductors. In addition, two emission peaks were observed in the fluorescence spectra which could be due to the formation of excimer and the interactions of the benzene and pyridine rings. The energy gap (ΔE_gap = E_LUMO - E_HOMO) of the complex has been calculated as 3.712 eV and this value is very close to the experimentally measured value (3.86 eV). Therefore, because of higher fluorescence intensity of emission peak that was observed between 309 and 556 nm wavelength besides other traits, the complex could potentially be used in the blue light OLED application by filtering of the emission peak around 710 nm wavelength. Graphical Abstract It was reported synthesis and spectroscopic, structural and optical characterization of a new complex that is Zn(II) of 4-Chlorophenylacetate with isonicotinamide. The complex characterized by elemental analysis, Single crystal X-ray diffraction and FT-IR Spectroscopy. Thermal stabilities of the complex have also been investigated. The studying of the optical absorption and fluorescence spectra of the prepared complex is very important for the determination of the optical application areas. The fluorescence measurements showed that these materials are much suitable for application area of the detection of nitroaromatic explosives. In addition to the Density Functional Theory (DFT) calculations were carried out to support the experimental results. It was reported synthesis and spectroscopic, structural and optical characterization of a new complex that is Zn(II) of 4-Chlorophenylacetate with isonicotinamide. The complex characterized by elemental analysis, Single crystal X-ray diffraction and FT-IR Spectroscopy. Thermal stabilities of the complex have also been investigated. The studying of the optical absorption and fluorescence spectra of the prepared complex is very important for the determination of the optical application areas. In addition to the Density Functional Theory (DFT) calculations were carried out to support the experimental results.

Enhanced activity of trinuclear Zn(ii) complexes towards phosphate ester bond cleavage by introducing three-metal cooperativity

The catalytic efficiency (DNA binding followed by phosphate ester bond cleavage) of Zn(ii) complexes has been tuned by variation in the nuclearity, flexibility and coordination environment to explore the structure activity correlation.

The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy

Prostate cancer cells control energy metabolism by chelating intracellular zinc. Thus, zinc delivery has been a popular therapeutic approach for prostate cancer. Here, we propose the use of the membrane-penetrating peptide Novicidin connected to zinc-Schiff base as a carrier vehicle for the delivery of zinc to prostate cells. Mass spectrometry, electrochemistry and spectrophotometry confirmed the formation/stability of this complex and provided insight regarding the availability of zinc for complex interactions. This delivery system showed minor toxicity in normal PNT1A cells and high potency towards PC3 tumor cells. The complex preferentially penetrated PC3 tumor cells in contrast to confinement to the membranes of PNT1A. Furthermore, zinc uptake was confirmed in both cell lines. Molecular analysis was used to confirm the activation of zinc stress (e.g., ZnT-1) and apoptosis (e.g., CASP-1). Our results strongly suggest that the zinc-Schiff base-Novicidin complex has great potential as a novel anticancer drug.

A triazole Schiff base-based selective and sensitive fluorescent probe for Zn²⁺: A combined experimental and theoretical study

A triazole-Schiff base, 4-(5-Chloro-2-hydroxybenzylideneamino)-1H-1,2,4-triazole-5(4H)-thione (HL), exhibits the high selectivity and sensitivity for Zn(2+) in the fluorescence spectrometry over other common metal ions, especially Cd(2+) in DMSO:H2O (1:9, v/v) solution. A 1:1 binding ratio of Zn(2+)/L for the complex has been obtained by Uv-Vis titration experiments and Job's plot with the detection limit of 51 nmol/L. The coordination mode of the complex in solution was further confirmed by density functional theory (DFT) calculations. Time-dependent density functional theory (TD-DFT) calculations indicate that a chelation-enhanced fluorescence (CHEF) effect occurs in the process of detecting Zn ion.

Ligand centered radical pathway in catechol oxidase activity with a trinuclear zinc-based model: synthesis, structural characterization and luminescence properties

A new trinuclear zinc(II) complex, [Zn3(L)(NCS)2](NO3)2·CH3OH·H2O (1), of a (N,O)-donor compartmental Schiff base ligand (H2L=N,N'-bis(3-methoxysalicylidene)-1,3-diamino-2-propanol), has been synthesized in crystalline phase. The zinc(II) complex has been characterized by elemental analysis, IR spectroscopy, UV-Vis spectroscopy, powder X-ray diffraction study (PXRD), (1)H NMR, EI mass spectrometry and thermogravimetric analysis. PXRD revealed that 1 crystallizes in P-1 space group with a=9.218 Å, b=10.849 Å, c=18.339 Å, with unit cell volume is 2179.713(Å)(3). Fluorescence spectra in methanolic solution reflect that intensity of emission for 1 is much higher compared to H2L and both the compounds exhibit good fluorescence properties. The complex 1 exhibits significant catalytic activities of biological relevance, viz. catechol oxidase. In methanol, it efficiently catalyzes the oxidation of 3,5-di-tert-butylcatechol (3,5-DTBC) to corresponding quinone via formation of a dinuclear species as [Zn2(L)(3,5-DTBC)]. Electron Paramagnetic Resonance (EPR) experiment suggests generation of radicals in the presence of 3,5-DTBC and it may be proposed that the radical pathway is probably responsible for conversion of 3,5-DTBC to 3,5-DTBQ promoted by complex of redox-innocent Zn(II) ion.

(Azido-κN){(E)-2-[1-(pyridin-2-yl)ethyl-idene-amino]-phenolato-κ(3) N,N',O}copper(II)

In the title complex, [Cu(C13H11N2O)(N3)], the Cu(II) cation is four-coordinated by an N2O donor set of the tridentate Schiff base ligand and by the terminal N atom of the azide anion, forming a slightly distorted square-planar configuration.